DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions:  Hematopoietic and Lymphoid Cell Neoplasm;  Recurrent Acute Lymphoblastic Leukemia;  Recurrent Acute Myeloid Leukemia;  Recurrent Chronic Myelomonocytic Leukemia;  Recurrent Myelodysplastic Syndrome;  Refractory Acute Lymphoblastic Leukemia;  Refractory Acute Myelo id Leukemia;  Refractory Chronic Myelomonocytic Leukemia;  Refractory Myelodysplastic Syndrome Interventions:  Biological: Antineoplastic Antibody-Drug Conjugate;  Drug: Azacitidine;  Drug: Cyclophosphamide;  Drug: Cytarabine;  Drug: Dexamethasone;  Biological: Filgrastim;  Drug: Leucovo...
Source: ClinicalTrials.gov - February 12, 2021 Category: Research Source Type: clinical trials
A Study of a New Way to Treat Children With a Brain Tumor Called NGGCT
Conditions:  Central Nervous System Nongerminomatous Germ Cell Tumor;  Embryonal Carcinoma;  Immature Teratoma;  Malignant Teratoma;  Mixed Germ Cell Tumor;  Pineal Region Germ Cell Tumor;  Pineal Region Immature Teratoma;  Pineal Region Yolk Sac Tumor Interventions:  Drug: Carboplatin;  Drug: Etoposide;  Biological: Filgrastim;  Drug: Ifosfamide;  Drug: Mesna;  Biological: Pegfilgrastim;  Procedure: Peripheral Blood Stem Cell Transplantation;  Other: Questionnaire Administration;  Radiation: Radiation Therapy;  Drug: Thiotepa Sponsor:  Children's OncologyÂ...
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials